Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV. (Q45281175)

11 December 2017

title

Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV. (English)

1 reference

11 December 2017

1 reference

11 December 2017

Trépo C

1 reference

11 December 2017

Ouzan D

1 reference

11 December 2017

Fontanges T

1 reference

11 December 2017

Chevallier M

1 reference

11 December 2017

Chossegros P

1 reference

11 December 2017

Degos F

1 reference

11 December 2017

Chevallier P

1 reference

11 December 2017

publication date

1 January 1986

1 reference

11 December 2017

published in

Journal of Hepatology

1 reference

11 December 2017

volume

3 Suppl 2

1 reference

11 December 2017

page(s)

S97-105

1 reference

Effect of Vidarabine on Chronic Hepatitis B Virus Infection

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Antiviral Treatment of Chronic Hepatitis B Virus Infection: Infectious Virus Cannot Be Detected in Patient Serum after Permanent Responses to Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2'-deoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Comparative study of DHBV DNA levels and endogenous DNA polymerase activity in naturally infected ducklings in France

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Comparison of properties of woodchuck hepatitis virus and human hepatitis B virus endogenous DNA polymerases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Antiviral therapy in hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Treatment of chronic hepatitis due to hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Comparative efficacy of adenine arabinoside 5' monophosphate and prednisone withdrawal followed by adenine arabinoside 5' monophosphate in the treatment of chronic active hepatitis type B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

Neurotoxicity associated with adenine arabinoside monophosphate in the treatment of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2886%2980106-4

7 January 2021

10.1016/S0168-8278(86)80106-4

Identifiers

DOI

1 reference

11 December 2017

1 reference